Psychedelics Move Toward the Mainstream: Lawyers’ Bird’s-Eye View from the Horizons Conference
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Perception, Psychedelics, and the Lap of Consciousness
What if the profound experience is not the destination but the invitation?
Psychedelic Depression Treatments Are Gaining Attention – What Comes Next?
An experimental psychedelic depression treatment just cleared a major clinical hurdle.
For some patients, psychedelic treatment brings new troubles in its aftermath
Psychedelics could transform mental health care, but some advocates and researchers say there needs to be more focus on the minority of people with persistent troubles after using...
UCSF Launches Study of Recreational Users of Shrooms, Other Psychedelics
UCSF is looking for a few good psychedelic drug enthusiasts to participate in a study about the effects of the drugs in recreational, non-lab settings, in the hope of finding new c...
Could My Patients Benefit From Psychedelics?
Medicine has developed many tools for suppressing suffering, but fewer for cultivating meaning or peace.
Peaking: Psychedelics and the Pursuit of Happiness
Memories of ‘Zonk” posters in my room, Dennis Hopper, Peter Fonda, Karen black in Easy Rider and the slogan “Turn on, tune... The post Peaking: Psychedelics and the Pursuit of Happ...
One with the world? A new look at brains transformed by psychedelics.
Participants meditated inside an MRI tube, with and without psilocybin.
Beyond Psilocybin: Sangam Healing Center Introduces a Unique Integrated approach to Natural Medicine and Personal transf...
Sangam Healing Center, based in Lakewood, Colorado, is bringing together traditional healing wisdom, contemporary mental Health perspectives, Ayurveda and Colorado's Natural Medici...
UPDATING ORIGINAL RELEASE: Dr. Angela Fisher Selected to Deliver Oral Remarks at FDA Public Hearing on the Future Therap...
The original release states, "clinical psychologist" next to founder and it should read, "founder of Bionic Bloom and the Neurodivergent Empowerment Institute, and creator of Empow...
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand...
FDA Floats Ibogaine Trial Design, Asks Field for Input On Monday, the day FDA’s Considerations for Potential Future Therapeutic Use of Psychedelic Drugs public comment period close...
Psychedelic Churches in a Time of Religious Exemption
Elizabeth Sepper, Yale Religious use of psychedelics is largely thought to be bookended by two Supreme Court decisions. The first, Employment Division v. Smith (1990), rejected a....
From Counterculture Threat to Venture Capital Darling
Once exclusive to Western counterculture, psychedelics have increasingly drawn the attention of medical researchers, corporations, and politicians. In April, Donald Trump signed an...
From Amazon retreats to clinical research: The rise of psychedelic therapy
Could hallucinogenic drugs become part of mainstream NHS care to treat depression?
LSD – from counterculture to clinical trials
From psychiatric research to counterculture and secret CIA mind-control experiments, LSD makes its way back to the lab.
Ten VA Sites, REMS and Ibogaine’s “Uphill Battle”: Feds Weigh In on Psychedelic Access
At the Psychedelic Healthcare Forum, which took place in New York City last Thursday and was co-hosted by Psychedelic Alpha, a panel of federal officials participated in a discussi...
Field Notes #6: Dispatches from D.C. as Three Psychedelics Land at FDA
Welcome to our sixth Field Note. As a reminder, Field Notes are timely, candid voice notes from our Founder and Editor, Josh Hardman, that give our Pα+ readers a pulse on recent de...
After a long, strange trip, this CEO is close to taking a psilocybin pill to market
Compass Pathways is on the cusp of FDA approval for a proprietary version of psilocybin — the active drug in magic mushrooms.
RN Collins (Series 3) No.9: Psychedelic Licensing Equity: What Cannabis’s Experience May Predict
RN Collins (Series 3) No.9 RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues. This is the 9th in the series Con...
80-Year-Old Alzheimer’s Patient Regains Speech After Magic Mushrooms Treatment
Spot the mushroom: it’s on the bucket hat in front of you, on the screen behind the DJ, stage designs and possibly on the cover of the album you’ve had on repeat. Magic mushrooms h...
Legal Shrooms Are Coming
Could psilocybin offer a breakthrough for treatment-resistant depression?
The secret world of Hasidic Jews who take psychedelic drugs to get closer to God
Raised among California hippies, Madison Margolin thought she knew all about drugs and spirituality. Then she met the Haredi psychedelic community
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.